Exalamide
Drug profile
Also known as: 2-n-Hexyloxybenzamide, hyperan
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Exalamide is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including HDAC6.
- Molecular targets: HDAC6 (1 listed in DrugCentral).
- Molecular formula: C13H19NO2; molecular weight 221.30 g/mol.
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Histone deacetylase 6 | HDAC6 | unknown | IC50 5.85 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Exalamide is on its molecule page.
| Molecular formula | C13H19NO2 |
|---|---|
| Molecular weight | 221.30 g/mol |
| CAS number | — |
| InChIKey | CKSJXOVLXUMMFF-UHFFFAOYSA-N |
| PubChem CID | 3316 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Exalamide work?
Its molecular targets in DrugCentral include HDAC6.
What is the chemical formula of Exalamide?
Exalamide has the molecular formula C13H19NO2 and a molecular weight of 221.30 g/mol.
Browse: all drugs starting with E · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1119 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1405973 — compound record and bioactivity
- PubChem CID 3316 — chemical identifiers
- FDA UNII 7JEC65JCG2 — substance identity
- UniProt Q9UBN7 (HDAC6) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.